♟️ Wednesday 29 July 2026 Wed, 29 July 2026

Metal Bank is pushing its Western Australian gold projects closer to production while expanding critical minerals exploration in Queensland, supported by a $1.2 million placement.

Liontown Limited reported a record $137 million net cash flow in the June quarter, boosting its cash reserves to $561 million and hitting a new high in underground development metres. The company is on track to reach a 2.8 Mtpa mining run-rate by the end of FY27, supported by strong lithium prices and steady operational progress.

Cue Energy Resources posted a solid quarter with a 16% production rise and $13.6 million cash receipts, backed by new drilling and a refreshed board after Horizon Oil's takeover.

Woodside Energy reported a 28% jump in Q2 operating revenue to $4.185 billion, propelled by a 35% rise in average realised prices despite a 9% dip in production volumes. Key LNG projects Scarborough, Trion, and Louisiana LNG progressed on schedule and budget, while Woodside increased its Browse Joint Venture stake to 41.27%.

Austin Metals has wrapped up a 4,216-metre RC drilling campaign at its Austin Gold Project, testing newly defined BIF-hosted gold targets at Brunswick Hill and Mt Sandy, with assay results still pending.

Stakk Ltd (ASX: SKK) has reported unaudited FY2026 revenue of A$14.68 million, beating prior guidance and delivering a 1,298% surge in customer cash receipts. The company also posted positive operating cash flow for the June quarter and anticipates further growth through its pending ParaScript acquisition.

PYC Therapeutics has made significant progress across its four RNA therapeutic programs, including dose escalation approvals in its Polycystic Kidney Disease trial and orphan drug designation for its Retinitis Pigmentosa candidate, supported by a robust cash position of $669 million.

Nodestream has advanced its defence strategy with key leadership hires, a $6.5 million capital raise, and fresh product launches, while expanding its footprint in the US and European markets.

Axel REE has confirmed a breakthrough in sustainable rare earth extraction at its Woolrich deposit, surpassing previous test benchmarks and preparing for field trials in December 2026.

TMK Energy reported a record gas output of around 28,000 scfd in June 2026, backed by a fully funded 2026 work program and key management hires. The company is progressing a 1MW gas-to-power pilot with Mongolia’s largest LPG distributor.

Sunstone Metals reported strong exploration progress in the June 2026 quarter at its Bramaderos and El Palmar gold-copper projects in Ecuador, highlighted by consistent long mineralised intersections and a $10 million capital raise.

Lion Rock Minerals has appointed a new leadership team with Sierra Rutile pedigree to drive development at its Minta Monazite & Rutile Project in Cameroon, backed by strong drilling results and a $2 million capital raise.

xReality Group delivered a robust Q4 FY26, with cash receipts up 46% to $6.9 million and net operating cash flow rising 64% to $2.2 million. The company completed a $5.6 million US Department of Defense project on time and secured its first European contract with the Swedish Armed Forces.

IRIS Metals is gearing up for a substantial tungsten drilling campaign in Montana while delivering a fresh lithium-rubidium resource estimate for its South Dakota project, underpinning its North American critical minerals ambitions.

Many Peaks Minerals has reported a landmark maiden Mineral Resource Estimate of 1.32 million ounces at its Ferké Gold Project, underpinning an aggressive exploration and development push supported by a A$27.5 million capital raise.

Cyclopharm’s Technegas® has been named the preferred ventilation agent in new US lung imaging guidelines, marking the first update in 14 years and potentially accelerating adoption across American hospitals.

Saluda Medical capped FY26 with a 28% revenue surge, beating guidance at US$90.2 million, while FDA approval for its CAP24 paddle lead opens a new US surgical market segment.

Prospect Resources has boosted its Mumbezhi Copper Project resource by 20%, notably doubling gold content, while commencing an extensive Phase 3 drilling program aimed at further expansion and upgrading.

Horizon Oil achieved record production and sales in FY26, driven by its Thailand assets, and completed the off-market takeover of Cue Energy, expanding its footprint across five countries.

DXN Limited has landed a $1.2 million contract for a key Pacific submarine cable project while advancing its maiden AI HPC modular data centre deal and expanding manufacturing in Southeast Asia.

Regener8 Resources (ASX:R8R) has finalised its 100% acquisition of the Srebrenica North polymetallic project in Bosnia and Herzegovina, initiated a systematic soil sampling program, and raised $1.415 million through a non-renounceable entitlement offer to fund exploration and working capital.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.

Vitrafy Life Sciences reported a breakthrough 94.4% post-thaw platelet recovery in US Army Phase II testing, secured major US blood network partnerships, and raised $32 million to accelerate US expansion and device manufacturing.

Adherium Limited has posted a fourth consecutive quarter of record remote patient monitoring revenue, driven by growing device activations and strong clinical evidence from the iCARE study, positioning the company for expanded value-based care contracts in the US.